跳至主要内容
临床试验/CTRI/2025/09/094698
CTRI/2025/09/094698尚未招募2 期

Efficacy of Joshanda Aftimoon orally with Zimad Kundush and shahed vs Latukh of Arad Adas and Gule Surkh in Palmoplantar psoriasis-A Randomised Comparative Clinical Trial

Government Unani Medical And Hospital1 个研究点 分布在 1 个国家目标入组 44 人开始时间: 2025年11月25日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
44
试验地点
1
主要终点
Reduction in m-PPPASI score

研究概览

简要总结

Psoriasis is a common genetically determined inflammatory skin disorder of unknown cause which in its most usual form is characterized by well demarcated raised red scaling patches that preferentially localize to the extensor surfaces

Most common sites of involvement are scalp elbow and knees hands feet trunk and nails Palmoplantar Psoriasis can occur alone on palms and soles or along with involvement of the other areas

It affects around 2 to 3 percent of the world population In India it affects about 0.8 to 8 percent population Among the types of Psoriasis prevalence of Palmoplantar Psoriasis is about 2.8 to 40.9 percent in psoriatic patients Psoriasis usually affects the age group between 15 to 50 years and less common below 10 years of age

In conventional medicine mild psoriasis is treated by topical application of emollients topical corticosteroids calcipotriene tazarotene topical tars anthralin and keratolytics

Mild psoriasis requires phototherapy or systemic therapy in combination with topical agents or phototherapy Systemic therapy includes Methotrexate Photo chemotherapy Narrow band UVB therapy Retinoids and Cyclosporine Biologics used for moderate to severe Psoriasis include Etanercept Alefacept Efalizumab Infliximab and Adalimumab And it is reserved for the patient who fail or cannot complete treatment with topical or systemic medications But these drugs exert adverse effects such as nausea dryness of mouth fatigue alopecia nephrotoxicity hepatotoxicity teratogenicity hypertension drug interaction

In Unani medicine the principle of treatment for Palmoplantar Psoriasis include Istefragh i Sawda and Mukhrij e Sawda Single drugs such as Afsantheen Aftimoon Halela Mundi Ushba Shoniz and Compound formulations such as Ayarijat and Maul jubn are used

However these drugs have not been scientifically explored so far Thus the present study entitled Efficacy of Joshanda Aftimoon orally along with Zimad Kundush and Shehad vs Latukh of Arad Adas and Gule Surkh in Palmoplantar Psoriasis A Randomized Comparative Clinical Trial is designed to provide safe more effective and economical treatment for Palmoplantar Psoriasis

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Clinically diagnosed cases of Palmoplantar Psoriasis 10-30 percent of area involved in one or both palms and soles as per m-PPPASI.

排除标准

  • Patients with uncontrolled DM and HTN Immunocompromised Patients Pregnant and Lactating Women History of treatment for psoriasis including PUVA Therapy and systemic steroids in past one month Patients suffering from HIV Impetigo Herpes zoster Eczema or any Fungal infections.

结局指标

主要结局

Reduction in m-PPPASI score

时间窗: 0thday 10thday 20thday 30thday

次要结局

  • Photographic changes(0thday and 30thday)

研究者

发起方
Government Unani Medical And Hospital
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Masiha Banu

Government Unani Medical College And Hospital

研究点 (1)

Loading locations...

相似试验